Imaging Modality to Identify Angiogenesis

Award Information
Agency:
Department of Defense
Branch
Army
Amount:
$69,995.00
Award Year:
2001
Program:
SBIR
Phase:
Phase I
Contract:
DAMD17-01-C-0020
Agency Tracking Number:
A002-1809
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
INTELLIGENT OPTICAL SYSTEMS, INC.
2520 W. 237th Street, Torrance, CA, 90505
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
033449757
Principal Investigator:
Allan Wang
Research Scientist
(310) 530-7130
awang@intopsys.com
Business Contact:
Robert Lieberman
Sr. Vice President & CTO
(310) 530-7130
rlieberman@intopsys.com
Research Institution:
n/a
Abstract
The goal of this project is to develop intelligent imaging software for the automated identification and analysis of angiogenesis. The project will demonstrate the feasibility of using this innovative technique for clinical angiography.The formation of newblood vessels (angiogenesis) is a critical component in a variety of physiological and pathological processes, such as in the healing of wounds, bone fractures, and ulcers and other angiogensis related diseases. There is, however, no software specificallydesigned for analyzing angiogenesis. Intelligent Optical Systems, Inc. (IOS) proposes to develop a user-friendly innovative method for the automatic, reliable, rapid, sensitive, and accurate identification and analysis of angiographies acquired fromMagnetic Resonance Imaging, computerized tomography, or Doppler ultrasound. This method will use neural network assisted imaging analysis software to identify and analyze the angiogenesis.This software will be useful in the diagnosis of angiogenesis inbone fractures, ulcers, cancer growth and metastasis, diabetes-induced retinal pathy, rheumatoid arthritis, and coronary disease. In addition, the timely analysis of angiogenesis may help soldiers avoid unnecessary surgical interventions and reduce injurymorbidity and mortality resulting from complications.Over 1000 research laboratories and 200 companies are engaged in angiogenesis research and development. These studies will potentially benefit over 65 million surgical patients, 10 million eye patients,7 million heart patients, and over 9 million cancer patients in the U.S. IOS will demonstrate the feasibility of this new technology by using innovative imaging analysis to meet the requirements for the specific, rapid, and accurate diognosis of clinicalangiography.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government